Inventor
ROGERS BRUCE NELSEN
US24 patents
Patents
24 patentsUS9527831B2Dec 27, 2016
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER13 citations92
US9428523B2Aug 30, 2016
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER12 citations92
US9315520B2Apr 19, 2016
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER15 citations92
US9139561B2Sep 22, 2015
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER8 citations92
US9107923B2Aug 18, 2015
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER11 citations92
US9133190B2Sep 15, 2015
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER8 citations84
US8822494B2Sep 2, 2014
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER12 citations84
US10093655B2Oct 9, 2018
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER3 citations83
US9845301B2Dec 19, 2017
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
PFIZER8 citations83
US9822097B2Nov 21, 2017
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER6 citations83
US9605007B2Mar 28, 2017
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER8 citations83
US9527843B2Dec 27, 2016
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER3 citations73
US10428034B2Oct 1, 2019
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
PFIZER3 citations72
US10421744B2Sep 24, 2019
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER2 citations72
US10028962B2Jul 24, 2018
2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER3 citations72
US9744173B2Aug 29, 2017
2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER2 citations72
US11964961B2Apr 23, 2024
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER0 citations62
US11014909B2May 25, 2021
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER0 citations62
US10077272B2Sep 18, 2018
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER0 citations52
US9868744B2Jan 16, 2018
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER1 citations52
US9745317B2Aug 29, 2017
Heterocyclic compounds and their use as dopamine D1 ligands
PFIZER1 citations52
US10723711B2Jul 28, 2020
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
PFIZER0 citations51
US10696658B2Jun 30, 2020
Heteroaromatic compounds and their use as dopamine D1 ligands
PFIZER0 citations51
US10316021B2Jun 11, 2019
Heteroarylphenoxy benzamide kappa opioid ligands
PFIZER0 citations35